The U.S. Food and Drug Administration (FDA) said on Thursday it has recommended five pharmaceutical firms to voluntarily recall their diabetes drug metformin after the agency found high levels of a possible cancer-causing impurity in some versions of the medication.
from Reuters: Health News https://ift.tt/2XbkyKB
via IFTTT
Thursday, May 28, 2020
Home »
Reuters: Health News
» U.S. FDA asks five firms to recall diabetes drug with high levels of probable carcinogen
0 comments:
Post a Comment